Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
6m
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
11m
on MSN
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
STAT
36m
‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs
A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Federal aid freeze suit
Pardoned rioter shot dead
Millions to die from heat?
Official portrait unveiled
Quakers sue over ICE policy
Joins NYC immigration raid
Worker killed on tarmac
‘King Creole' actress dies
Rebels enter Congo's Goma
Visa appointments canceled
Trial scheduled for Mar 2026
Mistaken FBI raid suit review
Won't run for reelection
IN grocery store shooting
Senior staff put on leave
More troops to border
Tesla, BMW sue EU
Seeks to pause Trump suit
Workers vote to unionize
Former chancellor files suit
To stop working with WHO
Consumer confidence dips
To power US data centers
Suspect arrested at Capitol
Heat suspend Butler again
Senate confirms Sean Duffy
Kilauea volcano erupts again
To cap MN insulin prices
To run for NM governor
WWE 2K25 cover star
Jim Acosta to exit CNN
Plane fire at SK airport
Announces ChatGPT Gov
Feedback